Article | bit.bio CEO featured in TechRound

January 17, 2022 | Featured on the TechRound 

Mark cells resized

CAMBRIDGE, Monday 17 January 2022 — bit.bio featured in TechRound's look forward at 2022.

bit.bio CEO Dr Mark Kotter joined several experts giving their thoughts on what is to come for the health sector in 2022. His focus was on what will happen in the cell therapy space coupled together with synthetic biology approaches.

Access the full article here.

 

 
“It is one of the most exciting developments in the life sciences – cell therapies have the potential to treat almost any human disease, including degenerative conditions or cancer.”
Mark Kotter

CEO bit.bio, TechRound January 2022

Latest news